Adoptive Transfer Of WT-1 Specific HLA Class 2 Restricted Donor-Derived T-cells Induces Sustained Remission Of AML Relapse Post Transplant Presenting As Leukemia Cutis

被引：0
|
作者：
Prockop, Susan E.
Doubrovina, Ekaterina
Adams, Roberta
Boulad, Farid
Kernan, Nancy A.
O'Reilly, Richard J.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2085.2085
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2085
引用
收藏
页数：2
相关论文
共 8 条
  • [1] Donor-Derived T-Cells Specific for WT1 and PRAME in Combination with T-Cells Specific for Multiple Pathogens for Prevention of Relapse and Infection after Haemopoietic Stem Cell Transplant (HSCT) for Acute Myeloid Leukaemia (AML) or High-Risk Myelodysplasia (MDS) - (The INTACT Trial)
    Jiang, Wei
    Blyth, Emily
    Shaw, Peter J.
    Clancy, Leighton Edward
    Micklethwaite, Kenneth P.
    Bhattacharyya, Abir
    Atkins, Elissa
    Avdic, Selmir
    Sutrave, Gaurav
    Street, Janine
    Gottlieb, David
    BLOOD, 2020, 136
  • [2] Long-term remission of post-transplant MDS/AML by adoptive transfer of allogeneic WT1-specific CD4+and CD8+T lymphocytes
    Kim, Y.
    Chung, N.
    Cho, S.
    Kim, M.
    Kim, E.
    Son, H.
    Choi, H.
    Kim, H.
    Min, C.
    Lee, S.
    Kim, D.
    Min, W.
    Kim, C.
    Kim, T.
    LEUKEMIA RESEARCH, 2009, 33 : S49 - S49
  • [3] Ex vivo generation of donor-derived WT1-specific cytotoxic T-cells able to lyse patient's leukaemia blasts for adoptive immunotherapy after allogeneic haematopoietic stem cell transplantation
    Turin, I.
    Lisini, D.
    Montini, E.
    Caliogna, L.
    Moretta, A.
    Bonetti, F.
    Zavras, N.
    Grecchi, I.
    Zecca, M.
    Maccario, R.
    Montagna, D.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S320 - S320
  • [4] Transferred Donor-Derived Virus Specific CD8+T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor Can Persist and Provide Anti-Leukemic Activity in AML Patients Post-Transplant
    Bar, Merav
    Chapuis, Aude G.
    Schmitt, Thomas M.
    Hieu Nguyen
    Duerkopp, Natalie A.
    Tom, Mark F.
    Wagener, Felecia D.
    Chaney, Colette N.
    Bui, Kieu-Thu
    Heimfeld, Shelly
    Greenberg, Philip D.
    BLOOD, 2014, 124 (21)
  • [5] Donor-derived EBV-specific cytotoxic T-cells are restricted by both donor unique and host unique HLA alleles following a fully allogeneic fetal liver and deficiency transplant for severe combined immuno-defiiciency (SCID).
    Koulova, L
    Young, JW
    O'Reilly, RJ
    BLOOD, 1998, 92 (10) : 266A - 266A
  • [6] NAIVE T-CELL-DERIVED CTL RECOGNIZE ATYPICAL EPITOPES OF CMVPP65 WITH HIGHER AVIDITY THAN CMV-SEROPOSITIVE DONOR-DERIVED CTL - A BASIS FOR TREATMENT OF POST-TRANSPLANT VIRAL INFECTION BY ADOPTIVE TRANSFER OF T-CELLS FROM VIRUS-NAIVE DONORS
    Hanley, P. J.
    Cruz, R. Y.
    Melenhorst, J.
    Scheinberg, P.
    Blaney, J.
    Savoldo, B.
    Dotti, G.
    Heslop, H.
    Rooney, C.
    Shpall, E. J.
    Barrett, J. A.
    Rodgers, J.
    Bollard, C. M.
    CYTOTHERAPY, 2013, 15 (04) : S9 - S9
  • [7] Preliminary analysis of a phase 1/2 study of NEXI-001 donor-derived multi-antigen-specific CD8+ T-cells for the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT).
    Al Malki, Monzr
    Vasu, Sumithira
    Modi, Dipenkumar
    Perales, Miguel-Angel
    Bui, Donna
    Edavana, Vineetha
    Kim, Sojung
    Suarez, Lauren
    Oelke, Mathias
    Bednarik, Dan
    Knight, Robert D.
    Varela, Juan Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Phase 1/2 Study of Nexi-001 Donor-Derived Multi-Antigen Specific CD8+T Cells for the Treatment of Relapsed Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Transplantation
    Al Malki, Monzr M.
    Vasu, Sumithira
    Modi, Dipenkumar
    Perales, Miguel-Angel
    Ghoda, Lucy Y.
    Bui, Donna
    Edavana, Vineetha
    Lu, Emily
    Kim, Sojung
    Suarez, Lauren
    Oelke, Mathias
    Bednarik, Daniel
    Knight, Robert D.
    Varela, Juan C.
    BLOOD, 2021, 138
1